Fluorescence-based screening of cytochrome P450 activities in intact cells

Methods in Molecular Biology

Volumn 987, Issue , 2013, Pages 135-148

  Donato, M Teresa ^a,b   Gómez Lechón, M José ^b,c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

Author keywords

Cell based assays; Cytochromes P450; Fluorogenic substrate

Indexed keywords

3 METHYLCHOLANTHRENE; CLOFIBRATE; CYTOCHROME P450; DEXAMETHASONE; DIETHYLDITHIOCARBAMIC ACID; FURAFYLLINE; KETOCONAZOLE; METHOXSALEN; PHENOBARBITAL; QUERCETIN; QUINIDINE; RIFAMPICIN; SULFAPHENAZOLE; TRANYLCYPROMINE; ENZYME INHIBITOR;

ARTICLE; CONTROLLED STUDY; COST; DRUG METABOLISM; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; METABOLIC RATE; MICROPLATE READER; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCREENING; BIOSYNTHESIS; CALIBRATION; CELL LINE; CULTURE TECHNIQUE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYME ASSAY; ENZYME INDUCTION; ENZYMOLOGY; FLUOROMETRY; LIVER CELL; METABOLISM; METHODOLOGY;

CALIBRATION; CELL CULTURE TECHNIQUES; CELL LINE; CYTOCHROME P-450 ENZYME SYSTEM; DRUG EVALUATION, PRECLINICAL; ENZYME ASSAYS; ENZYME INDUCTION; ENZYME INHIBITORS; FLUOROMETRY; HEPATOCYTES; HUMANS;

EID: 84882941221     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-321-3_12     Document Type: Article

References (25)

1. Cytochrome P450 home page (http://drnelson.utmem.edu/CytochromeP450.html)
2. Hewitt NJ, Gomez-Lechón MJ, Houston JB et al (2007) Primary hepatocytes: Current understanding of the regulation of metabolic enzymes, transporter proteins and how they are used in pharmaceutical practice. Drug Metab Rev 39:159-234
3. Lahoz A, Donato MT, Castell JV, Gómez-Lechón MJ (2008) Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometry. Curr Drug Metab 9:12-19
4. Donato MT, Jiménez N, Castell JV, Gómez-Lechón MJ (2004) Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos 32:699-706.5
5. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT (1995) Ethoxy-, pentoxy-, and benzyloxyphenoxasones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337-3345
6. Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL (2002) Cytochrome P450 fluorometric substrates: identi fication of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos 30: 845-852
7. White INH (1988) A continuous fluorimetric assay for cytochrome P-450-dependent mixed function oxidases using 3-cyano-7-ethoxycoumarin. Anal Biochem 172:304-310
8. Venhorst J, Onderwater RCA, Meerman JHN, Vermeulen NPE, Commandeur JNM (2000) Evaluation of a novel high-throughput assay for cytochrome P450 2D6 using 7-methoxy-4-(aminophenyl)-coumarin. Eur J Pharmaceut Sci 12:151-158
9. Chauret N, Dobss B, Lackman RL, Bateman K, Nicoll-Grif fith DA, Stresser DM, Ackermann JM, Turner SD, Miller V, Crespi CL (2001) The use of 3-[2-N, N-diethyl-N-methylammonium) ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a speci fic CYP2D6 probe in human liver microsomes. Drug Metab Dispos 29: 1196-1200
10. Chauret N, Tremblay N, Lackman RL, Gauthier JY, Silva JM, Marois J, Yergey JA, Nicoll-Grif fith DA (1999) Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe. Anal Biochem 276:215-226
11. Nerurkar PV, Park SS, Thomas PE, Nims RW, Lubet RA (1993) Methoxyresoru fin and benzyloxyresoru fin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol 46:933-943
12. Soars MG, Mcginnity DF, Grime K, Riley RJ (2007) The pivotal role of hepatocytes in drug discovery. Chem Biol Interact 168:2-15
13. Gómez-Lechón MJ, Castell JV, Donato MT (2008) An update on metabolism studies using human hepatocytes in primary culture. Expert Opin Drug Metab Toxicol 4:837-854
14. Gómez-Lechón MJ, Lahoz A, Gombau L, Castell JV, Donato MT (2010) In vitro evaluation of potential hepatotoxicity induced by new drugs. Curr Pharm Design 16:1963-1977
15. Gómez-Lechón MJ, Donato MT, Castell JV, Jover R (2004) Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr Drug Metab 5:443-462
16. Donato MT, Lahoz A, Castell JV, Gómez-Lechón MJ (2008) Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab 9:1-11
17. Pfeifer AMA, Cole KE, Smoot DT, Weston A, Groopman JD, Shields PG, Vignaud JM, Juillerat A, Lipsky MM, Trump BF, Lechner JF, Harris CC (1993) Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolise chemical carcinogens. Proc Natl Acad Sci 90:5123-5127
18. Bort R, Castell JV, Pfeifer A, Gómez-Lechón MJ, Macé K (1999) High expression of human CYP2C in immortalized human liver epithelial cells. Toxicol In Vitro 13:633-638
19. Donato MT, Castell JV (2003) Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. Clin Pharmacokinet 42:153-178
20. Donato MT, Gómez-Lechón MJ, Castell JV (1993) A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Anal Biochem 213:29-33
21. Lahoz A, Gombau L, Donato MT, Castell JV, Gómez-Lechón MJ (2006) In vitro ADME medium/high-throughput screening in drug preclinical development. Mini Rev Med Chem 6:1053-1062
22. Di Marco A, Yao D, Laufer R (2003) Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes. Eur J Biochem 270:376837-376877
23. Xu L, Chen Y, Pan Y, Skiles GL, Shou M (2009) Prediction of human drug-drug interactions from time-dependent inactivation of CYP3A4 in primary hepatocytes using a population-based simulator. Drug Metab Dispos 37:2330-2339
24. Guidance for industry: drug interaction studies -study design, data analysis, and implications for dosing and labelling. Guidance draft, 2006. Available at: www.fda.gov/cber/gdlns/interactstud.htm
25. Hewitt NJ, de Kanter R, LeCluyse E (2007) Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry -do they comply with FDA recommendations? Chem Biol Interact 168:51-65